A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient.
Invasive fungal infections are associated with high morbidity and mortality in immunocompromised patients. We describe an unusual case of concomitant invasive candidiasis and zygomycosis of the tongue and epiglottis that occurred in a young patient with neutropenia during chemotherapy for acute myelogenous leukemia and was successfully treated medically.
Chemaly
Roy F
RF
Department of Infectious Diseases, The Cleveland Clinic Foundation, Ohio 44195, USA.
Fox
Susan B
SB
Alkotob
Luay M
LM
Scharpf
Joseph
J
Sobecks
Ronald
R
Eliachar
Isaac
I
Procop
Gary W
GW
Smith
Mark
M
Avery
Robin K
RK
Schmitt
Steven K
SK
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D002175:Candida / Q000302:isolation & purification; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003561:Cytarabine / Q000009:adverse effects; D004825:Epiglottis / Q000382:microbiology*; D005658:Fungi / Q000302:isolation & purification; D006801:Humans; D015255:Idarubicin / Q000009:adverse effects; D016867:Immunocompromised Host; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009503:Neutropenia / Q000150:complications; D014059:Tongue / Q000382:microbiology* / Q000473:pathology; D014060:Tongue Diseases / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D020096:Zygomycosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology
D000935:Antifungal Agents; D000970:Antineoplastic Agents; D003561:Cytarabine; D000666:Amphotericin B; D015255:Idarubicin